Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
Phase 1
- Conditions
- Moderate and Severe Plaque Psoriasis
- Interventions
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Tianjin Ever Union Biotechnology Co., Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT03424629
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
🇨🇳Tianjin Ever Union Biotechnology Co., Ltd., Beijing, China
News
No news found